| Omacetaxine Mepesuccinate studied in …STUDIED_INderived34 of 34show fewer |
|---|
| → studied in | NCT07813390Phase 2 · enrolling by invitation Homoharringtonine, Lisaftoclax, and Azacitidine for AML After Venetoclax-Based Therapy Failure · 34 trials list this drug (15 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07131059NA · recruiting MRD-positive AML Clinical Study · 34 trials list this drug (15 active) | — | — | Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06265545NA · recruiting Multicenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid Leukemia · 34 trials list this drug (15 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06744556Phase 2 · active not recruiting HAV Versus DAV/IAV Induction Regimen in Elderly Patients With AML · 34 trials list this drug (15 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04501120Phase 1/Phase 2 · recruiting Study of Lisaftoclax (APG-2575) Single Agent and Combination With Therapy in Patients Relapsed/Refractory AML · 34 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07469046Phase 3 · not yet recruiting VAH vs VA in Newly Diagnosed Elderly AML · 34 trials list this drug (15 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07505160Phase 2 · not yet recruiting Efficacy and Safety of Lisafotoclax Plus Decitabine and Homoharringtonine in Venetoclax/Azacitidine Pretreated AML Patients · 34 trials list this drug (15 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07163910Phase 2 · recruiting Homoharringtonine Plus Androgen Deprivation Therapy in the Neoadjuvant Treatment of Prostate Cancer: A Single-Arm Clinical Study · 34 trials list this drug (15 active) | — | — | Malignant Prostate Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04874194Phase 1/Phase 2 · terminated Omacetaxine and Venetoclax for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Harboring Mutant RUNX1 · 34 trials list this drug (15 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Myelodysplastic Syndrome,Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07159906Phase 1/Phase 2 · not yet recruiting Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma · 34 trials list this drug (15 active) | — | — | Non-Hodgkin Lymphoma,Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06855810Phase 2/Phase 3 · recruiting Newly-diagnosed Pediatric T-cell ALL Protocol · 34 trials list this drug (15 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04126681Phase 2 · completed A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic Phase · 34 trials list this drug (15 active) | — | — | Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06361329Phase 3 · recruiting Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL · 34 trials list this drug (15 active) | — | — | Early T Precursor Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06742463Phase 2 · recruiting VHAG in Treating R/R T-ALL/LBL · 34 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05726110Phase 3 · recruiting Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia · 34 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06221683Phase 2 · recruiting Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML · 34 trials list this drug (15 active) | — | — | Acute Myeloid Leukemia,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05805072NA · unknown Selinexor and HAAG With/Without HMA in Relapsed/Refractory Acute Leukemia (AML) Patients · 34 trials list this drug (15 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05805098Phase 2/Phase 3 · recruiting Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML · 34 trials list this drug (15 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04248595Phase 2 · unknown Study of Azacitidine Combined With Homoharringtonie Based Regimens in AML · 34 trials list this drug (15 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00462943Phase 2 · completed Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CML · 34 trials list this drug (15 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00375219Phase 2 · completed Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation · 34 trials list this drug (15 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02078960Phase 1/Phase 2 · terminated A Study to Evaluate the Pharmacokinetics, Safety,and Efficacy of Omacetaxine Given Subcutaneously as a Fixed Dose in Patients With Chronic Phase (CP) or Accelerated Phase (AP) Chronic Myeloid Leukemia (CML) (Referred to as the SYNSINCT Study) · 34 trials list this drug (15 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02440568Phase 1/Phase 2 · terminated AML-02: Omacetaxine With Standard-of-Care Induction With Cytarabine & Idarubicin in Newly-Diagnosed AML Patients · 34 trials list this drug (15 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03135054Phase 2 · unknown Combination of Quizartinib and Omacetaxine Mepesuccinate for AML Carrying FLT3-ITD · 34 trials list this drug (15 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03170895Phase 2 · completed Combination of Sorafenib and Omacetaxine Mepesuccinate in Newly Diagnosed or Relapsed/Refractory AML Carrying FLT3-ITD · 34 trials list this drug (15 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004933Phase 3 · terminated Homoharringtonine Compared With Hydroxyurea for Chronic Myelogenous Leukemia That Has Not Responded to Interferon Alfa · 34 trials list this drug (15 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02029417Phase 2 · terminated Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia · 34 trials list this drug (15 active) | — | — | Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome,Adult Acute Megakaryoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01844869Phase 1 · completed An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate · 34 trials list this drug (15 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00114959Phase 2 · terminated Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML) · 34 trials list this drug (15 active) | — | — | Myeloid Leukemia,Chronic Myeloid Leukemia, BCR-ABL1 Positive,Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003694Phase 2 · completed Homoharringtonine Plus Low-Dose Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia in Chronic Phase · 34 trials list this drug (15 active) | — | — | Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00030355Phase 1/Phase 2 · withdrawn Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia · 34 trials list this drug (15 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002574Phase 2 · completed Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia · 34 trials list this drug (15 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006364Phase 2 · completed Homoharringtonine in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia · 34 trials list this drug (15 active) | — | — | Childhood Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Myeloid Leukemia, BCR-ABL1 Positive,Chronic Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003239Phase 2 · completed Chemotherapy and Biological Therapy in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia · 34 trials list this drug (15 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |